All codes
L690
L690 – Carcinoembryonic antigen (CEA)
OHIP Laboratory Medicine Code · Schedule of Benefits
Carcinoembryonic antigen (CEA). Listed under 2.3 Immunoassays in the Schedule of Benefits for Laboratory Services (effective April 1, 2026). [Essential Specifications 11] The carcinoembryonic antigen test (CEA) L690 is an insured service only when carried out in accordance with Cancer Care Ontario guidelines for following established malignancies, and not as a general cancer screen.
Ready to bill this code?
SnapBill makes OHIP billing simple — auto-filled codes, validation, and batch submission.